Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis

Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis

Objectives: Baricitinib is an orally active Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA). Materials and methods: Here, we report the case of a 56-year-old Caucasian male diagnosed with RA who developed palmoplantar pustulosis (PPP) while being t...

Full description

Bibliographic Details
Main Authors: Dimitra Koumaki, Vasiliki Koumaki, George Bertsias, Eleni Lagoudaki
Format: Article
Language:English
Published: SMC MEDIA SRL 2019-12-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
palmoplantar pustulosis
baricitinib
rheumatoid arthritis
cutaneous side effects
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/1383

Similar Items

Similar Items